中文簡(jiǎn)介

《臨床血脂學(xué)雜志》的出版是為了支持各種各樣的醫(yī)學(xué)專業(yè)人員，他們致力于降低血脂異常和相關(guān)脂質(zhì)代謝紊亂的發(fā)病率和死亡率。該雜志的讀者群涵蓋了醫(yī)學(xué)界的廣泛領(lǐng)域，包括心臟病學(xué)家、內(nèi)分泌學(xué)家和初級(jí)保健醫(yī)師，以及參與治療糖尿病、高血壓和肥胖等疾病的人。該雜志還介紹了治療上述患者基礎(chǔ)的聯(lián)合健康專家，如藥劑師、護(hù)士和營(yíng)養(yǎng)師。由于臨床血脂學(xué)的范圍很廣，該雜志所討論的主題也同樣多樣。典型文章探討了在治療環(huán)境中進(jìn)行的脂質(zhì)學(xué)，藥理學(xué)研究的最新進(jìn)展，治療和試驗(yàn)報(bào)告，案例研究，生活方式改變的影響，以及對(duì)從業(yè)者感興趣的類似學(xué)術(shù)材料。雖然優(yōu)先選擇直接實(shí)用的材料，但支持血脂學(xué)的科學(xué)是由專家貢獻(xiàn)者提出的，以便我們的讀者可以立即獲得循證方法來(lái)減少心血管和冠心病。該雜志的各部分將介紹開(kāi)創(chuàng)性研究和開(kāi)展這些研究的臨床醫(yī)生、案例研究、倫理標(biāo)準(zhǔn)和行為、專業(yè)指導(dǎo)，如ATP和NCE、編輯評(píng)論、讀者來(lái)信、國(guó)家脂質(zhì)協(xié)會(huì)（NLA）新聞和即將發(fā)布的事件信息，以及NLA年度科學(xué)報(bào)告的摘要。各分會(huì)在適當(dāng)時(shí)舉行的會(huì)議和科學(xué)論壇。

投稿網(wǎng)址：http://journalinsights.elsevier.com/journals/1933-2874

英文簡(jiǎn)介

The Journal of Clinical Lipidology is published to support the diverse array of medical professionals who work to reduce the incidence of morbidity and mortality from dyslipidemia and associated disorders of lipid metabolism. The Journal's readership encompasses a broad cross-section of the medical community, including cardiologists, endocrinologists, and primary care physicians, as well as those involved in the treatment of such disorders as diabetes, hypertension, and obesity. The Journal also addresses allied health professionals who treat the patient base described above, such as pharmacists, nurse practitioners and dietitians. Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. While preference is given to material of immediate practical concern, the science that underpins lipidology is forwarded by expert contributors so that evidence-based approaches to reducing cardiovascular and coronary heart disease can be made immediately available to our readers. Sections of the Journal will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.